04/25/2024 11:15 PM | Allogene Therapeutics (Filer)
| Form EFFECT | |
04/24/2024 3:18 PM | Allogene Therapeutics (Issuer) MOORE TIMOTHY L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/23/2024 3:31 PM | Allogene Therapeutics (Filer)
| Form DEF 14A | |
04/23/2024 3:32 PM | Allogene Therapeutics (Filer)
| Form DEFA14A | |
04/23/2024 3:33 PM | Allogene Therapeutics (Filer)
| Form ARS | |
04/22/2024 3:09 PM | Allogene Therapeutics (Subject) MOORE TIMOTHY L. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024 7:10 PM | Allogene Therapeutics (Issuer) Chang David D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/14/2024 4:28 PM | Allogene Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/14/2024 4:21 PM | Allogene Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/14/2024 3:51 PM | Allogene Therapeutics (Filer)
| Form POSASR | |
03/14/2024 3:55 PM | Allogene Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/14/2024 3:31 PM | Allogene Therapeutics (Subject) Chang David D (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024 8:52 PM | Allogene Therapeutics (Issuer) Parker Geoffrey M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 7:30 AM | Allogene Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 3:36 PM | Allogene Therapeutics (Subject) Belldegrun Arie (Filed by)
| Form SC 13G/A | |
02/09/2024 7:35 AM | Allogene Therapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
01/31/2024 4:45 PM | Allogene Therapeutics (Issuer) Roberts Zachary (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:46 PM | Allogene Therapeutics (Issuer) Belldegrun Arie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:47 PM | Allogene Therapeutics (Issuer) Parker Geoffrey M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:48 PM | Allogene Therapeutics (Issuer) Douglas Earl Martin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:51 PM | Allogene Therapeutics (Issuer) MOORE TIMOTHY L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:42 PM | Allogene Therapeutics (Issuer) Chang David D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 4:25 PM | Allogene Therapeutics (Subject) BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/24/2024 4:25 PM | Allogene Therapeutics (Issuer) Roberts Zachary (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 9:02 AM | Allogene Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024 3:11 PM | Allogene Therapeutics (Subject) Roberts Zachary (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 7:00 AM | Allogene Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2023 3:26 PM | Allogene Therapeutics (Issuer) MESSEMER DEBORAH M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 2:46 PM | Allogene Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2023 3:17 PM | Allogene Therapeutics (Subject) MESSEMER DEBORAH M. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023 3:41 PM | Allogene Therapeutics (Filer)
| Form 424B5 | |
10/25/2023 4:29 PM | Allogene Therapeutics (Subject) PFIZER INC (Filed by)
| Form SC 13D/A | |
10/17/2023 3:34 PM | Allogene Therapeutics (Filer)
| Form 8-K/A | |
10/16/2023 6:25 PM | Allogene Therapeutics (Issuer) Parker Geoffrey M. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/16/2023 7:31 AM | Allogene Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/17/2023 5:57 PM | Allogene Therapeutics (Issuer) Douglas Earl Martin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/17/2023 1:50 PM | Allogene Therapeutics (Issuer) Douglas Earl Martin (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/14/2023 6:59 PM | Allogene Therapeutics (Issuer) CHEN YINLIN JACK (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 6:28 PM | Allogene Therapeutics (Issuer) CHEN YINLIN JACK (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/02/2023 3:04 PM | Allogene Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2023 9:20 AM | Allogene Therapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G | |
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad) Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide |
06/29/2023 1:08 PM | Allogene Therapeutics (Subject) Bhavnagri Veer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2023 3:05 PM | Allogene Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2023 3:37 PM | Allogene Therapeutics (Subject) Bhavnagri Veer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023 4:02 PM | Allogene Therapeutics (Issuer) SATO VICKI L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 4:03 PM | Allogene Therapeutics (Issuer) Barrett Elizabeth A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 4:06 PM | Allogene Therapeutics (Issuer) MESSEMER DEBORAH M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 7:04 AM | Allogene Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2023 6:08 PM | Allogene Therapeutics (Subject) MOORE ALISON (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |